Imatinib vs Montelukast

## Imatinib vs Montelukast: Overview

This comparison examines the pharmacological differences between **Imatinib** and **Montelukast**.

## Mechanism of Action

**Imatinib**: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Imatinib — 18 hours; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Imatinib — C29H31N7O; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Imatinib — 493.6030 g/mol; Montelukast — 586.1800 g/mol.

**Type**: Imatinib — Small molecule; Montelukast — Small molecule.